Lilly releases Zepbound® (tirzepatide) single-dose vials, …
WEBINDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound ® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand.
Lilly launches lower-price weight loss drug without injector pen - CNN
WEBAug 27, 2024 — Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply...
News Release - Eli Lilly and Company
WEBNov 8, 2023 — News Release. FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems. Adults taking Zepbound in a clinical trial lost on average 48 lb. at the highest dose.
Zepbound: FDA approves Eli Lilly’s diabetes drug Mounjaro for ... - CNN
WEBNov 8, 2023 — The drug, called Mounjaro for diabetes, will be called Zepbound for weight loss, according to a news release from the FDA. Made by Eli Lilly, it’s part of a new class of drugs that includes ...
Weight loss drug Zepbound is now available, Eli Lilly says
WEBDec 6, 2023 — Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, had been approved by the...
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
WEBNov 9, 2023 — Here’s what you need to know about Lilly’s new drug. How well does Zepbound work? The active ingredient in Zepbound is tirzepatide, which mimics a hormone that helps reduce food cravings.
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
WEBNov 8, 2023 — The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
Zepbound: Eli Lilly releases new, cheaper form of weight loss drug
WEBAug 27, 2024 — Eli Lilly is offering 2.5-milligram and 5-milligram single-dose vials of Zepbound for $399 per month and $549 per month, respectively.
News Release - Eli Lilly and Company
WEBDec 11, 2023 — Zepbound™ (tirzepatide) injection is FDA-approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥ 30 kg/m 2), or overweight (BMI ≥ 27 kg/m 2) with at least one weight-related comorbid condition.
Zepbound price cut: Eli Lilly lowers cost of weight loss drug - NBC News
WEBAug 27, 2024 — Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply ...